Clinically Compliant hESC-RPE Cells Functionally Integrated in a Large-Eyed Preclinical Model

Drs. Outi Hovatta, Fredrik Lanner and Anders Kvanta at Karolinska Institutet have developed an effective retinal pigment epithelial (RPE) differentiation method using human recombinant laminin-521. They also established a large-eyed geographic atrophy model that allowed in vivo imaging of the hESC-RPE and host retina.

H&E-stained image of retina from albino rabbit showing photoreceptors rescued by hESC-RPE.
Courtesy of Dr. Anders Kvanta
  • Xeno-free and defined differentiation method
  • Suspension transplantation in a large-eyed disease model
  • Functional, polarized, monolayer cell integration
  • hESC-RPE cells exhibit characteristics of native RPE
  • Long-term phagocytic and photoreceptor rescue capacity

Bright-field imaging of hESC-RPE on laminin-521.
Courtesy of Dr. Fredrik Lanner
These findings have important implications for ongoing and future clinical studies for the development of a safe and efficient cell replacement therapy for geographic atrophy. The study is published in the journal Stem Cell Reports.
Interested in testing human recombinant laminins for your research? BioLamina offers a 10% evaluation discount on LN-521 RPE application.
Order through our web shop or via mention campaign code RPE2016.
Curious about the laminin technology? Visit BioLamina’s Science Room
Copyright © 2016 BioLamina, All rights reserved.

unsubscribe from this list    update subscription preferences